TNF and head and neck cancer: A study of the plasma from head and neck cancer cachectic patients showed the downregulation of plasmatic miR-130a expression correlated to a higher plasma concentration of tumor necrosis factor-alpha (TNF-α) and risk of being classified as cachectic [111].